What are the odds of dying from tuberculosis?
Evidence quality 4.88/5
Eight-dimension review score against the quality rubric . Each dimension scored 1–5.
- D1 Source grounding
- 5/5
- D2 Source authority
- 5/5
- D3 Arithmetic
- 5/5
- D4 Uncertainty
- 5/5
- D5 Scope
- 5/5
- D6 Prose
- 5/5
- D7 Perception honesty
- 4/5
- D8 Caveat completeness
- 5/5
● your factors — click this risk ▾ to reveal
- Your factors
≈ As likely as
Perceived
In wealthy countries, tuberculosis is widely treated as a 19th-century disease — the illness of Victorian novels, sanatoriums, and Keats, not of 2026. Most Likelier readers in the US, Western Europe, Japan, or Australia would guess their personal odds of dying from TB at essentially zero, and for them that guess is roughly correct. What the same readers almost universally get wrong is the global picture: TB has been the world’s leading infectious-disease killer for most of the past decade, it regained that title from COVID-19 in 2023, and it kills roughly twice as many people every year as HIV/AIDS. We have not found a cross-national survey that isolates “fear of dying from TB” as a clean question, so the perceived side here is editorial intuition, not polled data.
Rough estimate: Western readers treat it as a historical disease; the global burden is ~1.25 million deaths per year
Source: editorial intuition, not polled
Actual
~1.23 million global TB deaths per year (2024)
global, all ages (WHO Global TB Report 2025, reference year 2024)
Show derivation
Refreshed 2026-06-14 to the WHO Global Tuberculosis Report 2025 headline figure for reference year 2024: ~1.23 million TB deaths (including ~150,000 among people with HIV), a small decline from the ~1.25 million reported for 2023 in the 2024 report. Divided by a global population of ~8 billion gives an annual per-capita hazard of ~1.54 × 10⁻⁴. Compounded over 60 adult life-years: 1 − (1 − 1.54e-4)^60 ≈ 9.2 × 10⁻³, or roughly 1 in 109 global adult lifetime. The uncertainty band reflects the spread between WHO programmatic estimates (~1.23–1.25M) and GBD 2021 estimates (~1.35M), plus the WHO 95% UI on annual TB deaths. This is a global-average scale marker only — see the regional breakdown below. For residents of the US, Western Europe, Japan, and Australia, the actual figure is roughly five orders of magnitude lower.
Caveats: The ~1 in 110 figure is a global-average scale marker and is almost useless as a…
The ~1 in 110 figure is a global-average scale marker and is almost useless as a personal estimate. Tuberculosis mortality is overwhelmingly concentrated in eight countries (India, Indonesia, China, Philippines, Pakistan, Nigeria, Bangladesh, and South Africa) which together account for roughly two thirds of global cases, and within those countries risk is further concentrated in people living with HIV, in malnourished populations, in prisons and crowded institutional settings, and in household contacts of active cases. For residents of the US, Western Europe, Japan, and Australia without any of those risk factors, annual risk is ~1 in a million or lower — a gap of roughly five orders of magnitude versus the global headline. The global number has also been moving: TB deaths rose during 2020–2022 as COVID-19 disrupted TB programs, then began declining again. The WHO Global TB Report 2025 (reference year 2024) put deaths at ~1.23 million and ill people at 10.7 million — both modest declines from 2023 — while a record 8.3 million people were newly diagnosed and reported, the highest case count ever recorded (a detection/notification record, not a sign the epidemic grew). Drug-resistant TB remains a persistent gap: of the ~390,000 people who developed rifampicin-resistant TB in 2024, only about 42% — roughly 2 in 5 — accessed treatment (WHO Global TB Report 2025).
How the risk varies
The headline figure averages across very different situations. Here’s how the probability varies by scenario or context:
1 in 108
~1.25M TB deaths/yr across 8B people, compounded over 60 adult years. A scale marker, not a personal estimate.
1 in 25 · 4.0%
India alone accounts for roughly a quarter of global TB deaths; South and Southeast Asia together dominate the global incidence.
1 in 20 · 5.0%
HIV-TB co-infection drives case-fatality up from ~15% to closer to 40–50%; TB is the leading cause of death among people living with HIV.
1 in 20,000
Essentially absent as a population risk. CDC reports ~350 TB-attributed deaths per year in the US (~1 in a million annually).
Bar length and shade rank these scenarios against each other, not against other risks. The exact odds are shown beside each.
Related risks
Other risks on similar themes — for exploring related fears.
Benzo dependence
What are the odds of developing benzodiazepine dependence after a standard prescription?
Cat litter toxoplasmosis
What are the odds of acquiring a toxoplasma infection from cleaning a cat's litter box?
Childhood cancer diagnosis
What are the odds of a child being diagnosed with cancer before age 20?
Pick challenger
The World Health Organization’s Global Tuberculosis Report 2025 attributes roughly 1.23 million deaths to TB in reference year 2024, including about 150,000 among people living with HIV — a small decline from the ~1.25 million reported for 2023. That is still more than HIV/AIDS. It is more than malaria. And in 2023 TB had already reclaimed the title it held every year from 2014 to 2019, which the 2024 and 2025 reports both reaffirm: the world’s single deadliest infectious disease. An estimated 10.7 million people fell ill with TB in 2024, and a record 8.3 million were newly diagnosed and reported — the highest case count ever recorded, a detection milestone rather than a sign the epidemic grew, since estimated incidence actually edged down about 2% from 2023. The peer-reviewed Global Burden of Disease 2021 analysis, using a completely independent modeling pipeline, landed at ~1.35 million TB deaths — same order of magnitude, same conclusion. Averaged across 8 billion people and compounded over 60 adult years, the global headline lifetime figure is roughly 1 in 110.
What is genuinely strange about this fear is how badly the cultural imagination tracks the data. Most Likelier readers in wealthy countries file TB alongside cholera, typhus, and polio — diseases that used to matter before antibiotics, plumbing, and vaccines. That framing is correct for the US, where the CDC records ~350 TB-attributed deaths per year out of ~335 million people, a per-capita annual risk around one in a million. It is wrong for the world. TB is not a historical disease. It is an active epidemic that kills roughly as many people every year as live in a mid-sized American city, concentrated overwhelmingly in India, Indonesia, China, the Philippines, Pakistan, Nigeria, Bangladesh, and South Africa. The wealthy-country experience and the global experience of TB differ by roughly five orders of magnitude; both numbers are correct, they describe different populations.
The single largest piece of heterogeneity hiding behind the headline is the HIV-TB interaction. People living with HIV are about twelve times more likely to develop active TB than people without, TB is the leading cause of death among people living with HIV, and TB case-fatality climbs from roughly 15% in HIV-negative patients to something closer to 40–50% in untreated HIV-positive patients. That is why sub-Saharan Africa carries a disproportionate share of TB mortality relative to its caseload: the two epidemics are not separable there. The other large heterogeneities — malnutrition, household contact with an active case, crowded institutional settings — move individual risk by factors of 4 to 30 above the local average. The global 1 in 110 number is the right anchor for comparing TB to other infectious-disease fears on this site. It is the wrong anchor for almost any specific reader.
Related tidbits
Tuberculosis caused about 1.23 million deaths worldwide in 2024, putting the lifetime risk near 1 in 110 for a global adult. It reads as a historical disease in wealthy countries while remaining one of the deadliest infections elsewhere.
Claim ledger
Every number below is what each source reported, with the verbatim quote we relied on and how we arrived at our figure. Click any link to verify directly.
-
[1] World Health Organization — Global Tuberculosis Report 2025 — Factsheet
Global Tuberculosis Report 2025 — Factsheet- Statistic
TB caused an estimated 1.23 million deaths in 2024 (including 150,000 people with HIV); 10.7 million people fell ill with TB; 8.3 million were newly diagnosed and reported — a record high, up from 8.2 million in 2023 and 78% of estimated incident cases. 390,000 people developed RR-TB and only 164,545 (42%, ~2 in 5) were treated. TB is the world's leading cause of death from a single infectious agent.- Excerpt
“"Globally in 2024, TB caused an estimated 1.23 million deaths, including 150 000 people with HIV. … In 2024, an estimated 10.7 million people fell ill with TB worldwide, including 5.8 million men, 3.7 million women and 1.2 million children. … Globally in 2024, 8.3 million people were reported as newly diagnosed with TB in 2024 — a small increase from 8.2 million in 2023 and 78% of the estimated number of incident cases. … A total of 164 545 people were treated for rifampicin-resistant TB (RR-TB) in 2024. This was 42% of the approximately 390 000 people who developed RR-TB in 2024. … Tuberculosis (TB) is the world's leading cause of death from a single infectious agent and among the top 10 causes of death worldwide." ”
- Source data from
- 2025-11-14
- Accessed
- 2026-06-14
- Calculation
- WHO Global TB Report 2025 reports ~1.23 million annual TB deaths for reference year 2024, a small decline from the ~1.25 million reported for 2023. Divided by ~8 billion global population gives an annual per-capita hazard of ~1.54 × 10⁻⁴; compounded over 60 adult years yields 1 − (1 − 1.54e-4)^60 ≈ 9.2 × 10⁻³, i.e. roughly 1 in 109 — within the prior uncertainty band. The 8.3 million newly diagnosed/reported cases are the highest case count ever recorded (a diagnosis/notification record), while estimated incidence of 10.7 million actually fell ~2% from 2023; the two should not be conflated. MDR/RR-TB treatment access remains ~2 in 5 (42%).
- Independence
- WHO Global TB Report is the primary programmatic pipeline; this 2025 edition is the same WHO Global TB Programme source family as the 2024 edition below, used here as the most current reference-year headline.
-
[2] World Health Organization — Global Tuberculosis Report 2024 — 1.2 TB mortality
Global Tuberculosis Report 2024 — 1.2 TB mortality- Statistic
1.09 million TB deaths among HIV-negative people (95% UI 0.98–1.20 million) plus 161,000 deaths among people with HIV (95% UI 132,000–193,000) in 2023; ~1.25 million total. TB deaths from HIV-negative people (1.1 million) were almost double the deaths caused by HIV/AIDS (0.63 million).- Excerpt
“"Globally in 2023, there were an estimated 1.09 million deaths among HIV-negative people (95% uncertainty interval [UI]: 0.98–1.2 million) and an estimated 161 000 deaths among people with HIV (95% UI: 132 000–193 000). … The estimated number of deaths officially classified as caused by TB (i.e. those among HIV-negative people) in 2023, at 1.1 million, was almost double of the number of deaths caused by HIV/AIDS (0.63 million). … Now that COVID-19 has receded as a global public health emergency, in 2023 TB probably returned to being the leading cause of death from a single infectious agent." ”
- Source data from
- 2024-10-29
- Accessed
- 2026-04-11 · archived copy
- Calculation
- 1.09M HIV-negative + 161K HIV-positive = ~1.25M total annual TB deaths globally for reference year 2023. Divided by ~8 billion global population gives an annual per-capita hazard of 1.56 × 10⁻⁴; compounded over 60 adult years yields 1 − (1 − 1.56e-4)^60 ≈ 9.3 × 10⁻³, i.e. roughly 1 in 108. The ~95% uncertainty interval on HIV-negative TB deaths alone (0.98–1.20 million) plus the HIV-positive contribution drives the uncertainty band used in the normalized figure.
- Independence
- WHO Global TB Report is the primary programmatic pipeline — country-reported case/death notifications aggregated and modelled by the WHO Global TB Programme. Methodologically distinct from IHME's GBD Cause of Death Ensemble model (cited below), which uses overlapping upstream vital registration data but independent modelling; the two anchors genuinely triangulate the global figure.
-
[3] Lancet Infectious Diseases / GBD 2021 Tuberculosis Collaborators — Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021- Statistic
GBD 2021 estimated 9.40 million (95% UI 8.36–10.5) TB incident cases and 1.35 million (1.23–1.52) TB deaths in 2021. Global TB mortality fell ~12% between 2015 and 2020 — short of the WHO End TB Strategy 35% target. Mortality decline was 35.3% in children under 5 but only 3.3% in adults 70+.- Excerpt
“"The GBD 2021 study estimated 9.40 million (95% uncertainty interval [UI] 8.36 to 10.5) tuberculosis incident cases and 1.35 million (1.23 to 1.52) deaths due to tuberculosis in 2021. … Globally, between 2015 and 2020, the all-age tuberculosis incidence rate declined by 6.3% and tuberculosis mortality declined by 12%, both falling short of the WHO End TB Strategy 2020 milestones of 20% and 35% reductions, respectively." ”
- Source data from
- 2024-07-01
- Accessed
- 2026-04-11 · archived copy
- Calculation
- GBD 2021 is an independent modeling exercise from IHME and is the peer-reviewed corroboration of the WHO programmatic figure. GBD estimates ~1.35M TB deaths in 2021 vs WHO’s ~1.4M; the two systems agree on order of magnitude and on the conclusion that TB remains the leading infectious cause of death globally. The spread between the two headline estimates (~1.25M WHO 2023 vs ~1.35M GBD 2021) is the main driver of the upper end of the uncertainty band.
- Independence
- GBD is an IHME-led modeling exercise that uses its own cause-of-death pipeline and vital registration ensemble model, independent of WHO’s programmatic TB estimates. The two have known methodological differences (GBD typically reports slightly higher TB mortality than WHO) and are treated here as two genuinely independent anchors.
-
[4] US Centers for Disease Control and Prevention (CDC) — Deaths Among Persons with TB: 2010–2022 (Reported Tuberculosis in the United States, 2024)
Deaths Among Persons with TB: 2010–2022 (Reported Tuberculosis in the United States, 2024)- Statistic
858 deaths among US persons with TB in 2022 (most recent year with death data); of these, 349 (41%) were related to TB disease or TB therapy. Annual totals 2010–2022 range from 769 to 944.- Excerpt
“"In 2022, the most recent year for which death data are available, 858 deaths were reported by TB programs. … Of 858 deaths, 349 (41%) were related to TB disease or TB therapy. … Among 2022 deaths, 246 (29%) were among persons who were dead at diagnosis and 612 (71%) were among persons who died after diagnosis." ”
- Source data from
- 2024-10-24
- Accessed
- 2026-04-11 · archived copy
- Calculation
- CDC reports ~858 deaths per year among US persons with TB in 2022 but classifies only ~349 (41%) as actually caused by TB disease or therapy. Against a US population of ~335 million, the TB-attributed figure is ~1.0 × 10⁻⁶ per year — roughly 1 in a million per year, or ~6 × 10⁻⁵ (1 in ~16,000) compounded over 60 adult years. That is approximately 150 times lower than the global average and is the basis for the “US / Western Europe / Japan” row in the regional breakdown.
- Independence
- CDC US TB surveillance is a completely separate data pipeline from both WHO programmatic estimates and IHME’s GBD model. It is used here solely as the non-endemic anchor and is not in the triangulation of the global figure.